Overall Survival of Patients with Post-HCT Relapsed AML Has Not Improved in the Modern Era
Johnathan Fraebel(Baylor College of Medicine), Bhagirathbhai Dholaria(Vanderbilt University Medical Center), Reena Jayani(Vanderbilt University Medical Center), Michael Byrne(Vanderbilt University Medical Center), Brian G. Engelhardt(Vanderbilt University Medical Center)
Cited by 0
Related Papers
Geriatric Assessment–Driven Intervention (GAIN) on Chemotherapy-Related Toxic Effects in Older Adults With Cancer
|JAMA Oncology|2021|464
Standardizing Definitions of Hematopoietic Recovery, Graft Rejection, Graft Failure, Poor Graft Function, and Donor Chimerism in Allogeneic Hematopoietic Cell Transplantation: A Report on Behalf of the American Society for Transplantation and Cellular Therapy
|Transplantation and Cellular Therapy|2021|183
Outcomes of haploidentical vs matched sibling transplantation for acute myeloid leukemia in first complete remission
|Blood Advances|2019|128
Neurocognitive dysfunction in hematopoietic cell transplant recipients: expert review from the late effects and Quality of Life Working Committee of the CIBMTR and complications and Quality of Life Working Party of the EBMT
|Bone Marrow Transplantation|2018|104
The impact of the graft-versus-leukemia effect on survival in acute lymphoblastic leukemia
|Blood Advances|2019|101